(HAL) Halliburton - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4062161017
Stock: Completion, Drilling, Cementing, Wireline, Chemicals, Digital
Total Rating 69
Risk 95
Buy Signal 1.73
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.96% |
| Yield on Cost 5y | 3.71% |
| Yield CAGR 5y | 39.41% |
| Payout Consistency | 90.9% |
| Payout Ratio | 28.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -5.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 18.56 |
| Character TTM | |
|---|---|
| Beta | 1.243 |
| Beta Downside | 1.875 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.01% |
| CAGR/Max DD | -0.03 |
Description: HAL Halliburton December 19, 2025
Halliburton Company (NYSE: HAL) delivers a full suite of oilfield products and services worldwide, organized into two segments: Completion & Production, which handles well stimulation, cementing, intelligent completions, artificial-lift systems, and specialty chemicals; and Drilling & Evaluation, which provides drilling fluids, bit technology, wireline logging, digital AI platforms, and project-management services.
Recent performance highlights include Q4 2024 adjusted EBITDA of roughly $2.1 billion (≈12% YoY growth), a backlog of about $13 billion, and a breakeven oil price near $45 per barrel Brent-metrics that underscore the firm’s sensitivity to commodity cycles.
Key sector drivers remain robust upstream capital spending in North America’s shale plays, OPEC+ production discipline that sustains higher oil prices, and accelerating adoption of cloud-based analytics for subsurface optimization, all of which can amplify demand for Halliburton’s integrated service offerings.
For a deeper, data-driven view of HAL’s valuation outlook, you may find the tools on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.28b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -2.78 > 1.0 |
| NWC/Revenue: 26.19% < 20% (prev 27.60%; Δ -1.41% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.93b > Net Income 1.28b |
| Net Debt (6.64b) to EBITDA (3.30b): 2.01 < 3 |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (840.0m) vs 12m ago -4.87% < -2% |
| Gross Margin: 15.76% > 18% (prev 0.19%; Δ 1558 % > 0.5%) |
| Asset Turnover: 87.69% > 50% (prev 89.67%; Δ -1.98% > 0%) |
| Interest Coverage Ratio: 5.18 > 6 (EBITDA TTM 3.30b / Interest Expense TTM 418.0m) |
Altman Z'' 5.31
| A: 0.23 (Total Current Assets 11.40b - Total Current Liabilities 5.59b) / Total Assets 25.01b |
| B: 0.60 (Retained Earnings 15.04b / Total Assets 25.01b) |
| C: 0.09 (EBIT TTM 2.17b / Avg Total Assets 25.30b) |
| D: 1.19 (Book Value of Equity 17.33b / Total Liabilities 14.51b) |
| Altman-Z'' Score: 5.31 = AAA |
Beneish M -2.90
| DSRI: 1.00 (Receivables 4.94b/5.12b, Revenue 22.18b/22.94b) |
| GMI: 1.19 (GM 15.76% / 18.75%) |
| AQI: 1.07 (AQ_t 0.30 / AQ_t-1 0.28) |
| SGI: 0.97 (Revenue 22.18b / 22.94b) |
| TATA: -0.07 (NI 1.28b - CFO 2.93b) / TA 25.01b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of HAL shares?
As of February 07, 2026, the stock is trading at USD 34.98 with a total of 12,634,050 shares traded.
Over the past week, the price has changed by +4.36%, over one month by +13.46%, over three months by +28.81% and over the past year by +41.36%.
Over the past week, the price has changed by +4.36%, over one month by +13.46%, over three months by +28.81% and over the past year by +41.36%.
Is HAL a buy, sell or hold?
Halliburton has received a consensus analysts rating of 4.10.
Therefore, it is recommended to buy HAL.
- StrongBuy: 12
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.7 | 2.2% |
| Analysts Target Price | 35.7 | 2.2% |
| ValueRay Target Price | 37.6 | 7.5% |
HAL Fundamental Data Overview February 07, 2026
P/E Trailing = 22.56
P/E Forward = 14.9925
P/S = 1.3006
P/B = 2.7628
P/EG = 11.4241
Revenue TTM = 22.18b USD
EBIT TTM = 2.17b USD
EBITDA TTM = 3.30b USD
Long Term Debt = 7.16b USD (from longTermDebt, last quarter)
Short Term Debt = 526.0m USD (from shortTermDebt, last quarter)
Debt = 8.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.64b USD (from netDebt column, last quarter)
Enterprise Value = 35.49b USD (28.85b + Debt 8.85b - CCE 2.21b)
Interest Coverage Ratio = 5.18 (Ebit TTM 2.17b / Interest Expense TTM 418.0m)
EV/FCF = 21.23x (Enterprise Value 35.49b / FCF TTM 1.67b)
FCF Yield = 4.71% (FCF TTM 1.67b / Enterprise Value 35.49b)
FCF Margin = 7.54% (FCF TTM 1.67b / Revenue TTM 22.18b)
Net Margin = 5.78% (Net Income TTM 1.28b / Revenue TTM 22.18b)
Gross Margin = 15.76% ((Revenue TTM 22.18b - Cost of Revenue TTM 18.69b) / Revenue TTM)
Gross Margin QoQ = 16.56% (prev 15.39%)
Tobins Q-Ratio = 1.42 (Enterprise Value 35.49b / Total Assets 25.01b)
Interest Expense / Debt = 0.97% (Interest Expense 86.0m / Debt 8.85b)
Taxrate = 7.24% (46.0m / 635.0m)
NOPAT = 2.01b (EBIT 2.17b * (1 - 7.24%))
Current Ratio = 2.04 (Total Current Assets 11.40b / Total Current Liabilities 5.59b)
Debt / Equity = 0.84 (Debt 8.85b / totalStockholderEquity, last quarter 10.51b)
Debt / EBITDA = 2.01 (Net Debt 6.64b / EBITDA 3.30b)
Debt / FCF = 3.97 (Net Debt 6.64b / FCF TTM 1.67b)
Total Stockholder Equity = 10.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 1.28b / Total Assets 25.01b)
RoE = 12.34% (Net Income TTM 1.28b / Total Stockholder Equity 10.39b)
RoCE = 12.34% (EBIT 2.17b / Capital Employed (Equity 10.39b + L.T.Debt 7.16b))
RoIC = 11.22% (NOPAT 2.01b / Invested Capital 17.90b)
WACC = 8.24% (E(28.85b)/V(37.70b) * Re(10.49%) + D(8.85b)/V(37.70b) * Rd(0.97%) * (1-Tc(0.07)))
Discount Rate = 10.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.23%
[DCF Debug] Terminal Value 80.48% ; FCFF base≈1.97b ; Y1≈2.43b ; Y5≈4.14b
Fair Price DCF = 71.45 (EV 66.77b - Net Debt 6.64b = Equity 60.13b / Shares 841.6m; r=8.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.47 | EPS CAGR: 19.84% | SUE: 4.0 | # QB: 2
Revenue Correlation: 49.04 | Revenue CAGR: 7.70% | SUE: 2.01 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.51 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=17
EPS current Year (2026-12-31): EPS=2.23 | Chg30d=+0.029 | Revisions Net=+4 | Growth EPS=-7.7% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=2.68 | Chg30d=+0.019 | Revisions Net=+8 | Growth EPS=+20.1% | Growth Revenue=+3.8%
P/E Forward = 14.9925
P/S = 1.3006
P/B = 2.7628
P/EG = 11.4241
Revenue TTM = 22.18b USD
EBIT TTM = 2.17b USD
EBITDA TTM = 3.30b USD
Long Term Debt = 7.16b USD (from longTermDebt, last quarter)
Short Term Debt = 526.0m USD (from shortTermDebt, last quarter)
Debt = 8.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.64b USD (from netDebt column, last quarter)
Enterprise Value = 35.49b USD (28.85b + Debt 8.85b - CCE 2.21b)
Interest Coverage Ratio = 5.18 (Ebit TTM 2.17b / Interest Expense TTM 418.0m)
EV/FCF = 21.23x (Enterprise Value 35.49b / FCF TTM 1.67b)
FCF Yield = 4.71% (FCF TTM 1.67b / Enterprise Value 35.49b)
FCF Margin = 7.54% (FCF TTM 1.67b / Revenue TTM 22.18b)
Net Margin = 5.78% (Net Income TTM 1.28b / Revenue TTM 22.18b)
Gross Margin = 15.76% ((Revenue TTM 22.18b - Cost of Revenue TTM 18.69b) / Revenue TTM)
Gross Margin QoQ = 16.56% (prev 15.39%)
Tobins Q-Ratio = 1.42 (Enterprise Value 35.49b / Total Assets 25.01b)
Interest Expense / Debt = 0.97% (Interest Expense 86.0m / Debt 8.85b)
Taxrate = 7.24% (46.0m / 635.0m)
NOPAT = 2.01b (EBIT 2.17b * (1 - 7.24%))
Current Ratio = 2.04 (Total Current Assets 11.40b / Total Current Liabilities 5.59b)
Debt / Equity = 0.84 (Debt 8.85b / totalStockholderEquity, last quarter 10.51b)
Debt / EBITDA = 2.01 (Net Debt 6.64b / EBITDA 3.30b)
Debt / FCF = 3.97 (Net Debt 6.64b / FCF TTM 1.67b)
Total Stockholder Equity = 10.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 1.28b / Total Assets 25.01b)
RoE = 12.34% (Net Income TTM 1.28b / Total Stockholder Equity 10.39b)
RoCE = 12.34% (EBIT 2.17b / Capital Employed (Equity 10.39b + L.T.Debt 7.16b))
RoIC = 11.22% (NOPAT 2.01b / Invested Capital 17.90b)
WACC = 8.24% (E(28.85b)/V(37.70b) * Re(10.49%) + D(8.85b)/V(37.70b) * Rd(0.97%) * (1-Tc(0.07)))
Discount Rate = 10.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.23%
[DCF Debug] Terminal Value 80.48% ; FCFF base≈1.97b ; Y1≈2.43b ; Y5≈4.14b
Fair Price DCF = 71.45 (EV 66.77b - Net Debt 6.64b = Equity 60.13b / Shares 841.6m; r=8.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 28.47 | EPS CAGR: 19.84% | SUE: 4.0 | # QB: 2
Revenue Correlation: 49.04 | Revenue CAGR: 7.70% | SUE: 2.01 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.51 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=17
EPS current Year (2026-12-31): EPS=2.23 | Chg30d=+0.029 | Revisions Net=+4 | Growth EPS=-7.7% | Growth Revenue=-2.4%
EPS next Year (2027-12-31): EPS=2.68 | Chg30d=+0.019 | Revisions Net=+8 | Growth EPS=+20.1% | Growth Revenue=+3.8%